Beltone Hearing Aids Will Support Hands-Free Calls with iPhone and iPad Starting February 25

New bi-directional capability allows Beltone Imagine hearing aid microphones to pick up the user's voice so they can enjoy conversations completely hands-free

Beltone, the nation’s leading hearing care retailer, today announced that Beltone Imagine hearing aids will support hands-free calls to iPhone and iPad starting February 25.

With a free software update to the hearing aid, Beltone Imagine users will now be able to make and answer phone or FaceTime calls simply by tapping a button, using them like any other earbuds to listen and talk with friends, family, or co-workers.

Current Beltone patients with Beltone Imagine hearing aids and compatible Apple devices can utilize the hands-free feature starting Feb. 25 by visiting their local Beltone office and updating the software.

The recently announced new Beltone Imagine rechargeable BTE hearing aids, also available on Feb. 25, will already have the software needed for the hands-free feature.

This advance comes at a time when phone calls, video chats, and virtual meetings have surged as ways to stay connected. While Beltone hearing aids already support streaming audio of calls, music, and TV, this new bi-directional capability allows the hearing aid microphones to pick up the person’s voice so they can enjoy conversations completely hands-free.

“We’re excited Beltone patients can use their hearing aids as a hands-free device for making calls on their iPhone,” says Mike Halloran, Beltone President. “Now taking phones calls will be more convenient and comfortable for them. They won’t have to stop what they are doing…cooking, typing, walking, commuting…just to take a call. It’s yet another way Beltone stays right beside our patients, giving them great features and services that allow them to live life to the fullest.”

This feature is compatible with iPhone 11 or later, iPad Pro 12.9-inch (5th generation and 4th generation), iPad Pro 11-inch (3rd generation and 2nd generation), iPad Air (4th generation), and iPad mini (6th generation), running iOS 15.2 and iPadOS 15.2 or later.

Beltone Imagine is available exclusively at Beltone Hearing Centers nationwide. Every Beltone hearing aid automatically includes BelCare, a lifetime care and protection service available only with Beltone.  

Beltone Imagine hearing aids are an authorized Made for iPhone accessory and have been certified to meet Apple performance standards.

SourceBeltone

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”